These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33991607)

  • 21. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
    Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE
    Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enriched environment improves post-stroke cognitive impairment and inhibits neuroinflammation and oxidative stress by activating Nrf2-ARE pathway.
    Zhang X; Yuan M; Yang S; Chen X; Wu J; Wen M; Yan K; Bi X
    Int J Neurosci; 2021 Jul; 131(7):641-649. PubMed ID: 32677581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
    Sussan TE; Rangasamy T; Blake DJ; Malhotra D; El-Haddad H; Bedja D; Yates MS; Kombairaju P; Yamamoto M; Liby KT; Sporn MB; Gabrielson KL; Champion HC; Tuder RM; Kensler TW; Biswal S
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):250-5. PubMed ID: 19104057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
    Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
    Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nrf2-Dependent and -Independent Effects of
    Zagorski JW; Maser TP; Liby KT; Rockwell CE
    J Pharmacol Exp Ther; 2017 May; 361(2):259-267. PubMed ID: 28280124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
    Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo.
    Wible RS; Tran QT; Fathima S; Sutter CH; Kensler TW; Sutter TR
    Mol Pharmacol; 2018 Apr; 93(4):297-308. PubMed ID: 29367259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant mechanism of catalpol: Involvement of the PI3K/Akt/Nrf2/HO-1 signaling pathway in rat hippocampus.
    Wang J; Chen R; Liu C; Wu X; Zhang Y
    Eur J Pharmacol; 2021 Oct; 909():174396. PubMed ID: 34332921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
    Aminzadeh MA; Reisman SA; Vaziri ND; Khazaeli M; Yuan J; Meyer CJ
    Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.
    Townson JL; Macdonald IC; Liby KT; Mackenzie L; Dales DW; Hedley BD; Foster PJ; Sporn MB; Chambers AF
    Clin Exp Metastasis; 2011 Mar; 28(3):309-17. PubMed ID: 21234655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
    Ji Y; Lee HJ; Goodman C; Uskokovic M; Liby K; Sporn M; Suh N
    Mol Cancer Ther; 2006 Jun; 5(6):1452-8. PubMed ID: 16818503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemic preconditioning provides long-lasting neuroprotection against ischemic stroke: The role of Nrf2.
    Yang T; Sun Y; Li Q; Li S; Shi Y; Leak RK; Chen J; Zhang F
    Exp Neurol; 2020 Mar; 325():113142. PubMed ID: 31812555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Nrf2 in D-Galactose-Induced Cardiac Aging in Mice: Involvement of Oxidative Stress.
    Yang X; Jia J; Ding L; Yu Z; Qu C
    Gerontology; 2021; 67(1):91-100. PubMed ID: 33271531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats.
    Martín-Hernández D; Bris ÁG; MacDowell KS; García-Bueno B; Madrigal JL; Leza JC; Caso JR
    Neuropharmacology; 2016 Apr; 103():79-91. PubMed ID: 26686388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echinacoside ameliorates post-stroke depression by activating BDNF signaling through modulation of Nrf2 acetylation.
    Yang Z; Zhao Y; Wang Y; Liu X; Jiang Y; Jiang Y; Liu T; Hu Y; Chang H
    Phytomedicine; 2024 Jun; 128():155433. PubMed ID: 38547621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor beta-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complex.
    To C; Kulkarni S; Pawson T; Honda T; Gribble GW; Sporn MB; Wrana JL; Di Guglielmo GM
    J Biol Chem; 2008 Apr; 283(17):11700-13. PubMed ID: 18283107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.
    Thimmulappa RK; Scollick C; Traore K; Yates M; Trush MA; Liby KT; Sporn MB; Yamamoto M; Kensler TW; Biswal S
    Biochem Biophys Res Commun; 2006 Dec; 351(4):883-9. PubMed ID: 17097057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice.
    Fitzpatrick LR; Stonesifer E; Small JS; Liby KT
    Inflammopharmacology; 2014 Dec; 22(6):341-9. PubMed ID: 24715223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
    Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
    Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel Nrf2 activator CDDO-EA attenuates cerebral ischemic injury by promoting microglia/macrophage polarization toward M2 phenotype in mice.
    Lei X; Li H; Li M; Dong Q; Zhao H; Zhang Z; Sun B; Mao L
    CNS Neurosci Ther; 2021 Jan; 27(1):82-91. PubMed ID: 33280237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.